Adjuvant therapy node-negative breast cancer use prognostic factors patients Patients invasive breast cancer negative lymph nodes NO favorable survival rate small cm primary tumors Overall recurrence local therapy Adjuvant chemotherapy tamoxifen disease-free survival DFS overall survival OS Unanswered questions optimal end point DFS OS risk many clinicians prognostic indicators treatment recommendations available accurate information TNM pathologic features hormone receptors Ploidy S-phase fraction amplification over-expression cathepsin-D useful prognostic indices precise system several prognostic variables decision adjuvant systemic therapy good prognosis group patient physician Whenever possible patients clinical trials 